Literature DB >> 15361868

Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6.

Taro Kawai1, Shintaro Sato, Ken J Ishii, Cevayir Coban, Hiroaki Hemmi, Masahiro Yamamoto, Kenta Terai, Michiyuki Matsuda, Jun-ichiro Inoue, Satoshi Uematsu, Osamu Takeuchi, Shizuo Akira.   

Abstract

Toll-like receptors (TLRs) are involved in the recognition of microbial pathogens. A subset of TLRs, TLR7, TLR8 and TLR9, induces antiviral responses by producing interferon-alpha (IFN-alpha). Production of IFN-alpha is dependent on the Toll-interleukin-1 receptor domain-containing adaptor MyD88. Here we show that MyD88 formed a complex with the transcription factor IRF7 but not with IRF3. The death domain of MyD88 interacted with an inhibitory domain of IRF7, and this interaction resulted in activation of the IFN-alpha-dependent promoters. Furthermore, the adaptor molecule TRAF6 also bound and activated IRF7. Ubiquitin ligase activity of TRAF6 was required for IRF7 activation. These results indicate that TLR-mediated IFN-alpha induction requires the formation of a complex consisting of MyD88, TRAF6 and IRF7 as well as TRAF6-dependent ubiquitination.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15361868     DOI: 10.1038/ni1118

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  358 in total

1.  The dual functions of IL-1 receptor-associated kinase 2 in TLR9-mediated IFN and proinflammatory cytokine production.

Authors:  Youzhong Wan; Tae Whan Kim; Minjia Yu; Hao Zhou; Michifumi Yamashita; Zizhen Kang; Weiguo Yin; Jian-An Wang; James Thomas; Ganes C Sen; George R Stark; Xiaoxia Li
Journal:  J Immunol       Date:  2011-01-26       Impact factor: 5.422

Review 2.  Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion.

Authors:  Søren Jensen; Allan Randrup Thomsen
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

Review 3.  Association of MicroRNA-146a with autoimmune diseases.

Authors:  Wang-Dong Xu; Man-Man Lu; Hai-Feng Pan; Dong-Qing Ye
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

4.  Virus-activated interferon regulatory factor 7 upregulates expression of the interferon-regulated BST2 gene independently of interferon signaling.

Authors:  Mariana G Bego; Johanne Mercier; Eric A Cohen
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

5.  Myxoma virus induces type I interferon production in murine plasmacytoid dendritic cells via a TLR9/MyD88-, IRF5/IRF7-, and IFNAR-dependent pathway.

Authors:  Peihong Dai; Hua Cao; Taha Merghoub; Francesca Avogadri; Weiyi Wang; Tanvi Parikh; Chee-Mun Fang; Paula M Pitha; Katherine A Fitzgerald; Masmudur M Rahman; Grant McFadden; Xiaoyu Hu; Alan N Houghton; Stewart Shuman; Liang Deng
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

6.  Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling.

Authors:  Chi-You Chang; Helene Minyi Liu; Ming-Fu Chang; Shin C Chang
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

7.  Regulatory serine residues mediate phosphorylation-dependent and phosphorylation-independent activation of interferon regulatory factor 7.

Authors:  Alexandre Caillaud; Ara G Hovanessian; David E Levy; Isabelle J Marié
Journal:  J Biol Chem       Date:  2005-03-02       Impact factor: 5.157

Review 8.  DNA-stimulated cell death: implications for host defence, inflammatory diseases and cancer.

Authors:  Søren R Paludan; Line S Reinert; Veit Hornung
Journal:  Nat Rev Immunol       Date:  2019-03       Impact factor: 53.106

Review 9.  Extracellular DNA and autoimmune diseases.

Authors:  Hantao Lou; Matthew C Pickering
Journal:  Cell Mol Immunol       Date:  2018-03-19       Impact factor: 11.530

Review 10.  Trafficking of endosomal Toll-like receptors.

Authors:  Bettina L Lee; Gregory M Barton
Journal:  Trends Cell Biol       Date:  2014-01-15       Impact factor: 20.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.